Despite the fact that beta-blockers, vasodilators, statins and angiotensin-converting enzyme inhibitors can reduce the plasma level of endothelin-1 [5], the groups of CHD patients were comparable in terms of the rates of prescriptions of these drugs (see Section 2.1). The gene discussed is ACE; the disease is coronary artery disorder.